Adda Corporation (TPEX:3071)

Sage Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,684	1,550	1,497	1,163	933.44	1,121
Short-Term Investments	5.11	5.01	4.8	4.86	-	-
Trading Asset Securities	13.03	16.92	8.26	18.25	16.25	11.53
Cash & Short-Term Investments	1,702	1,572	1,510	1,186	949.69	1,133
Cash Growth	13.37%	4.12%	27.26%	24.93%	-16.18%	28.48%
Accounts Receivable	619.32	734.46	569.69	744.92	759.41	546.63
Other Receivables	37.89	32.71	35.36	56.33	38.39	25.21
Receivables	657.21	767.17	605.04	801.25	797.8	571.85
Inventory	299.63	312.64	268.26	382.04	411.06	238.48
Prepaid Expenses	47.68	38.68	83.44	47.31	31.23	21.21
Other Current Assets	63.99	68.74	14.87	156.34	105.48	95.47
Total Current Assets	2,771	2,759	2,482	2,573	2,295	2,060
Property, Plant & Equipment	837.95	843.7	827.48	790.75	656.78	624.3
Long-Term Investments	45.45	47.44	60.23	52.09	51.54	54.92
Goodwill	219.92	219.92	219.92	219.92	49.29	49.29
Other Intangible Assets	47.72	51.26	63.05	76.81	4.21	6.63
Long-Term Deferred Tax Assets	29.41	38.64	53.07	53.56	53.84	44.48
Other Long-Term Assets	105.37	105.48	78.96	91.26	100.42	144.76
Total Assets	4,057	4,066	3,784	3,858	3,211	2,984
Accounts Payable	317.38	392.62	335.14	376.28	472.29	330.01
Accrued Expenses	108.56	117.46	115.52	124.71	111.25	-
Short-Term Debt	915.82	870.87	817.13	751.66	488.4	467.25
Current Portion of Long-Term Debt	-	-	-	-	10	-
Current Portion of Leases	19.27	19.76	17.75	9.1	9.38	9.55
Current Income Taxes Payable	74.15	73.69	73.54	107.63	91.86	61.85
Current Unearned Revenue	7.91	5.27	16.08	4.07	13.69	4.59
Other Current Liabilities	255.61	291.07	267.16	355.14	254.58	362.88
Total Current Liabilities	1,699	1,771	1,642	1,729	1,451	1,236
Long-Term Debt	140	140	100	100	138.21	118.89
Long-Term Leases	117.2	118.68	125.65	9.91	11.52	19.65
Long-Term Deferred Tax Liabilities	5.22	4.65	3.06	5.47	10.44	13.03
Other Long-Term Liabilities	61.8	59.78	64.71	66.65	63.87	71.1
Total Liabilities	2,023	2,094	1,936	1,913	1,683	1,472
Common Stock	1,100	1,100	1,100	1,100	1,100	1,100
Additional Paid-In Capital	60.58	60.35	58.17	52.04	40.5	38.88
Retained Earnings	423.75	421.35	441.84	497.19	448.37	414.9
Treasury Stock	-	-	-	-6.55	-14.93	-17.79
Comprehensive Income & Other	-9.89	-50.51	-123.78	-90.33	-139.47	-122.19
Total Common Equity	1,574	1,531	1,476	1,552	1,434	1,414
Minority Interest	459.33	440.86	372.12	392.74	93.78	98.79
Shareholders' Equity	2,034	1,972	1,848	1,945	1,528	1,513
Total Liabilities & Equity	4,057	4,066	3,784	3,858	3,211	2,984
Total Debt	1,192	1,149	1,061	870.67	657.51	615.35
Net Cash (Debt)	510.08	422.91	449.46	315.82	292.18	517.59
Net Cash Growth	4.89%	-5.91%	42.31%	8.09%	-43.55%	12.72%
Net Cash Per Share	4.64	3.84	4.09	2.89	2.68	4.74
Filing Date Shares Outstanding	110	110	110	109.59	109.07	108.89
Total Common Shares Outstanding	110	110	110	109.59	109.07	108.89
Working Capital	1,072	988.72	839.29	844.86	843.8	823.81
Book Value Per Share	14.31	13.92	13.42	14.16	13.15	12.98
Tangible Book Value	1,307	1,260	1,193	1,256	1,381	1,358
Tangible Book Value Per Share	11.88	11.45	10.85	11.46	12.66	12.47
Land	121.11	119.96	88.63	89.66	88.19	91.22
Buildings	785.07	774.11	738.17	749.15	522.8	370.84
Machinery	645.28	629.54	624.27	653.19	488.2	449.74
Construction In Progress	11.74	10.55	-	0.24	0.63	95.56
Leasehold Improvements	46.53	45.67	49.39	50.91	50.02	51.59

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.